Advertisement

TriSalus Life Sciences, Inc. TLSI

Set alert

Price alert · TLSI

All alert types
3.70 USD -0.16 -4.15%

At close · Oct 30

3.70 0.00 0.00%

After hours · Oct 30, 4:00 PM ET

Bid
3.70 × 2
Ask
3.71 × 2
3.66 Day range 3.87
2.52 52-week range 7.50
YTD
-46.99%
1 year
-20.77%
Open
3.77
Prev close
3.86
Mkt cap
227.83M
Vol
108.59K
Avg vol
262.58K
EPS
-1.22
P/E
0.00
Div yield
0.00%
More statistics
Low
3.66
High
3.87
Forward P/E
-3.50
Beta
0.50
Short ratio
2.38
Inst. own
17.27%
Dividend
0.00
Ex-div date
Earnings
Aug 14, 2024
50-d avg
4.14
200-d avg
6.29
1y target
11.64

5D chart

Chart tools
Interval

Signals (114)
NameTimeAgo
MACD: Sell SignalOct 29, 10:40 AM2 days ago
RSI: OverboughtOct 28, 3:40 PM3 days ago
SMA: BullishOct 28, 3:25 PM3 days ago
MACD: Buy SignalOct 28, 3:25 PM3 days ago
MACD: Sell SignalOct 28, 3:20 PM3 days ago
SMA: BearishOct 28, 2:00 PM3 days ago
SMA: BullishOct 28, 1:55 PM3 days ago
SMA: BullishOct 28, 1:55 PM3 days ago
MACD: Buy SignalOct 28, 1:55 PM3 days ago
MACD: Sell SignalOct 28, 1:35 PM3 days ago
MACD: Buy SignalOct 28, 1:20 PM3 days ago
SMA: BullishOct 28, 12:40 PM3 days ago
MACD: Sell SignalOct 28, 12:05 PM3 days ago
SMA: BearishOct 28, 12:00 PM3 days ago
SMA: BearishOct 28, 12:00 PM3 days ago
MACD: Buy SignalOct 28, 11:25 AM3 days ago
SMA: BullishOct 28, 11:20 AM3 days ago
SMA: BearishOct 28, 10:45 AM3 days ago
SMA: BullishOct 28, 10:40 AM3 days ago
MACD: Sell SignalOct 28, 10:30 AM3 days ago
SMA: BearishOct 28, 10:25 AM3 days ago
SMA: BearishOct 28, 10:25 AM3 days ago
MACD: Buy SignalOct 28, 10:05 AM3 days ago
SMA: BullishOct 28, 10:00 AM3 days ago
SMA: BullishOct 28, 10:00 AM3 days ago
MACD: Sell SignalOct 28, 9:45 AM3 days ago
SMA: BearishOct 28, 9:40 AM3 days ago
MACD: Buy SignalOct 28, 9:35 AM3 days ago
RSI: OverboughtOct 28, 9:35 AM3 days ago
SMA: BearishOct 27, 3:20 PM4 days ago
MACD: Sell SignalOct 27, 3:20 PM4 days ago
RSI: OverboughtOct 27, 2:45 PM4 days ago
SMA: BullishOct 27, 2:05 PM4 days ago
SMA: BullishOct 27, 2:05 PM4 days ago
MACD: Buy SignalOct 27, 2:05 PM4 days ago
RSI: OverboughtOct 27, 2:05 PM4 days ago
SMA: BearishOct 27, 1:55 PM4 days ago
SMA: BearishOct 27, 1:55 PM4 days ago
MACD: Sell SignalOct 27, 12:45 PM4 days ago
SMA: BearishOct 27, 12:40 PM4 days ago
MACD: Buy SignalOct 27, 11:55 AM4 days ago
SMA: BullishOct 27, 11:50 AM4 days ago
SMA: BullishOct 27, 11:50 AM4 days ago
SMA: BearishOct 27, 11:30 AM4 days ago
MACD: Sell SignalOct 27, 11:30 AM4 days ago
MACD: Buy SignalOct 27, 10:55 AM4 days ago
SMA: BullishOct 27, 10:45 AM4 days ago
SMA: BullishOct 27, 10:45 AM4 days ago
MACD: Sell SignalOct 27, 10:10 AM4 days ago
SMA: BearishOct 27, 10:05 AM4 days ago
SMA: BearishOct 27, 10:05 AM4 days ago
SMA: BullishOct 27, 9:30 AM4 days ago
SMA: BullishOct 27, 9:30 AM4 days ago
MACD: Buy SignalOct 27, 9:30 AM4 days ago
RSI: OverboughtOct 27, 9:30 AM4 days ago
MACD: Sell SignalOct 26, 3:45 PM5 days ago
MACD: Buy SignalOct 26, 3:25 PM5 days ago
MACD: Sell SignalOct 26, 3:10 PM5 days ago
SMA: BearishOct 26, 3:05 PM5 days ago
MACD: Buy SignalOct 26, 2:40 PM5 days ago
SMA: BullishOct 26, 2:30 PM5 days ago
SMA: BullishOct 26, 2:30 PM5 days ago
SMA: BearishOct 26, 2:15 PM5 days ago
SMA: BearishOct 26, 1:50 PM5 days ago
MACD: Sell SignalOct 26, 1:50 PM5 days ago
SMA: BearishOct 26, 1:30 PM5 days ago
MACD: Buy SignalOct 26, 1:20 PM5 days ago
SMA: BearishOct 26, 1:00 PM5 days ago
MACD: Sell SignalOct 26, 1:00 PM5 days ago
SMA: BullishOct 26, 12:45 PM5 days ago
MACD: Buy SignalOct 26, 12:45 PM5 days ago
MACD: Sell SignalOct 26, 12:40 PM5 days ago
SMA: BearishOct 26, 12:35 PM5 days ago
MACD: Buy SignalOct 26, 12:25 PM5 days ago
SMA: BullishOct 26, 12:15 PM5 days ago
SMA: BullishOct 26, 12:15 PM5 days ago
SMA: BearishOct 26, 12:05 PM5 days ago
SMA: BullishOct 26, 12:00 PM5 days ago
MACD: Sell SignalOct 26, 11:45 AM5 days ago
SMA: BearishOct 26, 11:30 AM5 days ago
SMA: BullishOct 26, 10:40 AM5 days ago
MACD: Buy SignalOct 26, 10:40 AM5 days ago
MACD: Sell SignalOct 26, 10:35 AM5 days ago
SMA: BearishOct 26, 10:30 AM5 days ago
SMA: BearishOct 26, 10:30 AM5 days ago
SMA: BullishOct 26, 10:20 AM5 days ago
SMA: BullishOct 26, 10:20 AM5 days ago
MACD: Buy SignalOct 26, 10:20 AM5 days ago
SMA: BearishOct 26, 10:10 AM5 days ago
SMA: BearishOct 26, 10:10 AM5 days ago
MACD: Sell SignalOct 26, 10:10 AM5 days ago
SMA: BullishOct 26, 10:05 AM5 days ago
SMA: BullishOct 26, 10:05 AM5 days ago
MACD: Buy SignalOct 26, 10:05 AM5 days ago
MACD: Sell SignalOct 26, 9:45 AM5 days ago
SMA: BearishOct 26, 9:40 AM5 days ago
SMA: BearishOct 26, 9:40 AM5 days ago
SMA: BullishOct 26, 9:30 AM5 days ago
RSI: OverboughtOct 26, 9:30 AM5 days ago
SMA: BearishOct 23, 3:55 PM1 week ago
SMA: BearishOct 23, 3:55 PM1 week ago
SMA: BullishOct 23, 3:35 PM1 week ago
MACD: Buy SignalOct 23, 3:35 PM1 week ago
MACD: Sell SignalOct 23, 3:25 PM1 week ago
RSI: OversoldOct 23, 3:15 PM1 week ago
SMA: BearishOct 23, 2:35 PM1 week ago
MACD: Buy SignalOct 23, 2:10 PM1 week ago
RSI: OversoldOct 23, 1:50 PM1 week ago
RSI: OversoldOct 23, 1:25 PM1 week ago
RSI: OversoldOct 23, 1:05 PM1 week ago
SMA: BearishOct 23, 12:35 PM1 week ago
SMA: BearishOct 23, 12:35 PM1 week ago
SMA: BullishOct 23, 12:15 PM1 week ago
SMA: BearishOct 23, 11:35 AM1 week ago

Key statistics

Market cap
125.94M
Enterprise value
121.48M
Trailing P/E
0.00
Forward P/E
-3.50
PEG ratio
0.00
Price / sales
5.09
Price / book
0.00
EPS (TTM)
-1.92
Beta
0.50
Dividend yield
0.00%
Payout ratio
0.00%
Profit margin
-219.71%
Revenue (TTM)
24.74M
Revenue growth
59.70%
Free cash flow
-52.96M
Total cash
16.48M
Total debt
22.76M
Return on equity
0.00%
Shares outstanding
30.49M
Short % of float
0.32%
50-day average
4.14
200-day average
6.29

Analyst view

Consensus: strong buy

Strong buy
Price target (mean) 11.64 +214.7% upside
Target (low)
10.00
Target (mean)
11.64
Target (high)
16.00
Ratings (0m) 7 7 buy · 0 hold · 0 sell
  • Strong buy2
  • Buy5
  • Hold0
  • Sell0
  • Strong sell0

Next earnings

Aug 14, 2024

Expected Aug 14, 2024. Consensus EPS estimate -0.35.

Earnings history

Financials — quick view

All financials
TLSI Revenue — quarterly 11.41M
2022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026
TLSI Net income — quarterly -9.19M
2022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026
TLSI EPS — quarterly -0.16
2022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026

Earnings

TLSI recent earnings
Report dateQuarter endingEPS estimateEPS reportedSurpriseSurprise %
Nov 14, 2024Sep 1, 2024-0.36-0.40-0.04-11.11%
Aug 14, 2024Jun 1, 20240.00-0.21——
Aug 14, 2024Jun 1, 20240.00———
May 15, 2024Mar 1, 20240.00———
May 15, 2024Mar 1, 20240.00-0.54——
Apr 1, 2024Dec 1, 20230.00-1.56——

Upgrades / downgrades

TLSI analyst upgrades and downgrades
DateFirmActionFromTo
Dec 17, 2024Cantor Fitzgeraldinit—Overweight
Nov 15, 2024Canaccord GenuitymainBuyBuy
Nov 11, 2024Roth MKMinit—Buy
Oct 25, 2024Northland Capital Marketsinit—Outperform
Sep 16, 2024Oppenheimerinit—Outperform
Jun 27, 2024Canaccord GenuitymainBuyBuy

About TriSalus Life Sciences, Inc.

TriSalus Life Sciences, Inc., a medical technology company, researches, develops, and sells drug delivery technologies and immune-oncology therapeutics for the treatment of liver and pancreatic cancer. The company offers Pressure Enabled Drug Delivery infusion systems, such as the TriNav infusion system, which is used in transarterial radioembolization and chemoembolization procedures for patients with liver cancer and metastases; and the Pancreatic Retrograde Venous Infusion device, which is in Phase 1 clinical trial, for locally advanced pancreatic cancer. It also develops nelitolimod, an investigational immunotherapeutic in Phase 1 clinical trial for the treatment of uveal melanoma with liver metastases, hepatocellular carcinoma, intrahepatic cholangiocarcinoma, and locally advanced pancreatic ductal adenocarcinoma. The company serves interventional radiologists, IR technicians, medical oncologists, nursing support, value analysis committee staff, and patients through its sales representatives and sales managers. TriSalus Life Sciences, Inc. was founded in 2009 and is headquartered in Westminster, Colorado.

Sector
Healthcare
Industry
Medical Devices
Country
United States

News

Your note

Sign in to keep a note on TLSI — it syncs with the Stock Master app.

Insider holders

TLSI insider holders
InsiderRelationLatest transactionDateShares held
COX BRYAN FOfficerSaleOct 3, 202486,382
DESAI ARJUN JJDirectorSaleDec 9, 2024247,127
FRANKENIUS EQUITY ABBeneficial Owner of more than 10% of a Class of SecurityPurchaseDec 16, 20246,230,750
KATZ STEVEN C.OfficerStock Award(Grant)Feb 11, 202468,587
MARSHAK RICHARDOfficerStock Award(Grant)Nov 13, 202434,126
MARTIN GEORGE KELLYDirectorSaleAug 27, 20240

Institution ownership

TLSI institution ownership
Holder% heldSharesValueReported
Wealthcare Advisory Partners LLC2.11%643,7402.66MSep 29, 2024
Duquesne Family Office Llc1.40%426,9211.76MSep 29, 2024
Vanguard Group Inc1.36%416,1381.72MSep 29, 2024
Geode Capital Management, LLC0.66%200,427827.76KSep 29, 2024
Millennium Management Llc0.32%97,888404.28KSep 29, 2024
Exos Asset Management LLC0.13%38,604159.43KSep 29, 2024

Fund ownership

TLSI fund ownership
Holder% heldSharesValueReported
Vanguard Total Stock Market Index Fund0.82%248,8771.03MSep 29, 2024
Vanguard Extended Market Index Fund0.53%162,125669.58KSep 29, 2024
Fidelity Extended Market Index Fund0.34%102,494423.30KOct 30, 2024
Fidelity Total Market Index Fund0.11%34,186141.19KOct 30, 2024
Fidelity Series Total Market Index Fund0.08%24,313100.41KOct 30, 2024
Fidelity NASDAQ Composite Index Fund0.06%17,23971.20KOct 30, 2024
Advertisement